Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma
Clinical trial NCT03655483 · UNKNOWN
Trial details
- NCT number
- NCT03655483
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2021-04-11
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.